Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
R&D Systems™ Recombinant Human CD19 Fc Chimera Protein
Click to view available options
:
Quantity: 50μg
Description
The Recombinant Human CD19 Fc Chimera Protein is derived from CHO. The Recombinant Human CD19 Fc Chimera Protein has been validated for the following applications: Bioactivity.
Order Info
The product is shipped at ambient temperature.
Specifications
Specifications
Accession Number | P15391 |
For Use With (Application) | Bioactivity |
Formulation | Lyophilized from a 0.2μm filtered solution in PBS and NaCl |
Gene ID (Entrez) | 930 |
Molecular Weight (g/mol) | 77 to 92 kDa, reducing conditions |
Name | B4, B-lymphocyte antigen CD19, B-lymphocyte surface antigen B4, CD19, CD19 antigen, CD19 molecule, CVID3, Differentiation antigen CD19, Leu-12, MGC12802, T-cell surface antigen Leu-12 |
Quantity | 50μg |
Source | Chinese Hamster Ovary cell line,CHO-derived human CD19 protein, (N-terminus) Human CD19 (Glu21-Lys291) Accession &Num; P15391 IEGRMD Human IgG1 (Pro100-Lys330) (C-terminus) |
Storage Requirements | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution. |
Regulatory Status | RUO |
Show More |
For Research Use Only
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction